A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma
Hee Yeon Kim, Jin Dong Kim, Si Hyun Bae, Jun Yong Park, Kwang Hyub Han, Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Byoung Kuk Jang, Jae Seok Hwang, Sang Gyune Kim, Young Seok Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Korean Liver Cancer Study Group
Korean J Hepatol. 2010;16(4):355-361.   Published online 2010 Dec 31     DOI: https://doi.org/10.3350/kjhep.2010.16.4.355
Citations to this article as recorded by Crossref logo
Upregulation of microRNA‐140‐3p inhibits epithelial‐mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN
Qiu‐Yin Zhang, Chang‐Jun Men, Xue‐Wei Ding
Journal of Cellular Biochemistry.2019; 120(9): 14885.     CrossRef
MRI-Compatible Injection System for Magnetic Microparticle Embolization
Ning Li, Francois Michaud, Zeynab Nosrati, Dumitru Loghin, Charles Tremblay, Rosalie Plantefeve, Katayoun Saatchi, Urs O. Hafeli, Sylvain Martel, Gilles Soulez
IEEE Transactions on Biomedical Engineering.2019; 66(8): 2331.     CrossRef
Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Hwan Choi, Woo Jin Chung, Si Hyun Bae, Do Seon Song, Myeong Jun Song, Young Seok Kim, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Jun Yong Park, Do Young Kim, Seung Up Kim, Sung Bum Cho
Cancer Chemotherapy and Pharmacology.2018; 82(3): 469.     CrossRef
Two cases of the hepatocellular carcinoma with portal vein tumor thrombus treated with DEB-TACE effectively
Hironori Ochi, Akihisa Ohno, Kazuhiro Tange, Michiko Aono, Shunji Takechi, Toshie Mashiba, Tomoyuki Yokota, Kouji Joko
Kanzo.2017; 58(1): 28.     CrossRef
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clinical and Molecular Hepatology.2017; 23(2): 128.     CrossRef
Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study
Min-Ke He, Yong Le, Qi-Jiong Li, Zi-Shan Yu, Shao-Hua Li, Wei Wei, Rong-Ping Guo, Ming Shi
Chinese Journal of Cancer.2017;[Epub]     CrossRef
Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review
Kichang Han
World Journal of Gastroenterology.2016; 22(1): 407.     CrossRef
Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5-fluorouracil
Kazuto Tajiri, Kengo Kawai, Masami Minemura, Satoshi Yasumura, Ayumu Hosokawa, Hideto Kawabe, Gakuto Tomizawa, Toshiro Sugiyama
Hepatology Research.2015; 45(7): 755.     CrossRef
A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Do Seon Song, Myeong Jun Song, Si Hyun Bae, Woo Jin Chung, Jae Young Jang, Young Seok Kim, Sae Hwan Lee, Jun Yong Park, Hyung Joon Yim, Sung Bum Cho, Soo Young Park, Jin Mo Yang
Journal of Gastroenterology.2015; 50(4): 445.     CrossRef
Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: A meta-analysis
Zhouying Zheng, Wenhua Liang, Dongping Wang, Paul M. Schroder, Weiqiang Ju, Linwei Wu, Zheng Zheng, Yushu Shang, Zhiyong Guo, Xiaoshun He
International Journal of Cancer.2015; 136(6): E751.     CrossRef
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Myeong Jun Song
World Journal of Gastroenterology.2015; 21(13): 3843.     CrossRef
Chemoembolization alonevscombined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients
Song Gao
World Journal of Gastroenterology.2015; 21(36): 10443.     CrossRef
Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments
Takahiro Yamasaki, Issei Saeki, Isao Sakaida
Hepatology International.2014; 8(S2): 492.     CrossRef
Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma
Ming-Chun Ma, Yen-Yang Chen, Shau-Hsuan Li, Yu-Fan Cheng, Chih-Chi Wang, Tai-Jan Chiu, Sung-Nan Pei, Chien-Ting Liu, Tai-Lin Huang, Chen-Hua Huang, Yu-Li Su, Yen-Hao Chen, Sheng-Nan Lu, Kun-Ming Rau
The Scientific World Journal.2014; 2014: 1.     CrossRef
Newer treatments for advanced hepatocellular carcinoma
Myeong Jun Song, Si Hyun Bae
The Korean Journal of Internal Medicine.2014; 29(2): 149.     CrossRef
A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
Akihiko Osaki, Takeshi Suda, Kenya Kamimura, Atsunori Tsuchiya, Yasushi Tamura, Masaaki Takamura, Masato Igarashi, Hirokazu Kawai, Satoshi Yamagiwa, Yutaka Aoyagi
Cancer Medicine.2013; 2(1): 86.     CrossRef
Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review
Yan Zhao, Guohong Cai, Lin Zhou, Lei Liu, Xingshun Qi, Ming Bai, Yongping Li, Daiming Fan, Guohong Han
Asia-Pacific Journal of Clinical Oncology.2013; 9(4): 357.     CrossRef
Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan
Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita, Toru Kimura
Cancers.2012; 4(1): 165.     CrossRef
Which treatment modality should we choose for advanced hepatocellular carcinoma?
Do Young Kim
The Korean Journal of Hepatology.2010; 16(4): 353.     CrossRef